Compare
Medtronic vs Insulet (MDT vs PODD)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Medtronic (MDT) returned +12.6% and Insulet (PODD) -53.4%; so far this year the figures are +6.0% and -48.5%.
Medtronic is the larger company by market value, about 12.8 times the size of Insulet.
On trailing earnings, MDT trades at 25.0 times and PODD at 23.9 times.
Revenue grew +9.8% at MDT and +26.5% at PODD over the last year.
MDT yields 2.81%. PODD pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| MDT | PODD | |
|---|---|---|
| Price | $101.80 | $146.51 |
| 1-day | -2.90% | -6.16% |
| YTD | +5.98% | -48.46% |
| 1 year | +12.61% | -53.41% |
| 3 years | +43.68% | +6.38% |
| Market cap | $130.2B | $10.2B |
| P/E | 25.0 | 23.9 |
| P/S | 3.47 | 3.19 |
| P/B | 2.59 | 6.44 |
| Revenue growth | +9.80% | +26.50% |
| EPS growth | +12.10% | +78.20% |
| Gross margin % | 65.0 | 71.9 |
| Net margin % | 13.9 | 13.4 |
| ROE % | 10.4 | 27.2 |
| Debt / equity | 0.56 | 0.61 |
| FCF yield % | 4.7 | 2.6 |
| Dividend yield % | 2.81 | — |
| Beta | 0.14 | 0.41 |
| RSI (14) | 63.8 | 49.6 |
| Technical rating |